Hydrazones as a privileged structural linker in antitubercular agents: a review
Bijo Mathew1, Jerad Suresh, Mohamed J Ahsan
1Division of Drug Design and Medicinal Chemistry Research Lab, Department of Pharmaceutical Chemistry, Grace; College of Pharmacy, Palakkad-678004, Kerala, India. bijovilaventgu@gmail.com.
Infectious Disorders Drug Targets
|July 25, 2015
Summary
Hydrazone derivatives show promise as antitubercular agents due to their unique chemical structure. This review explores their chemistry, activity, and structure-activity relationships for developing new tuberculosis treatments.
Area of Science:
- Medicinal Chemistry
- Organic Chemistry
- Pharmacology
Background:
- Hydrazones are versatile organic linkers with hydrogen bonding capabilities.
- Hydrazone derivatives have demonstrated significant potential as antitubercular agents.
- Research into hydrazone-based compounds for tuberculosis treatment is ongoing.
Purpose of the Study:
- To review the chemistry of phenyl and heterocyclic hydrazones.
- To summarize the antitubercular activity of various hydrazone derivatives.
- To analyze the structure-activity relationships (SAR) of these compounds.
Main Methods:
- Literature review of scientific publications.
- Analysis of chemical structures and properties of hydrazones.
- Correlation of structural features with antitubercular activity.
Main Results:
- Diverse classes of phenyl and heterocyclic hydrazones exhibit potent antitubercular activity.
- Specific structural features are linked to enhanced efficacy.
- Structure-activity relationship (SAR) data provides insights for drug design.
Conclusions:
- Hydrazone derivatives represent a promising scaffold for novel antitubercular drug discovery.
- Understanding SAR is crucial for optimizing the potency and selectivity of these agents.
- Further research can lead to the development of effective treatments for tuberculosis.

![Cercosporin-Photocatalyzed [4+1]- and [4+2]-Annulations of Azoalkenes Under Mild Conditions](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60786.jpg&w=3840&q=50)
